Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons.

Turner EA, Atigh MK, Erwin MM, Christians U, Yazdani SK.

Cardiovasc Eng Technol. 2018 Jun;9(2):240-250. doi: 10.1007/s13239-018-0346-1. Epub 2018 Mar 1.

2.

Factor Structure and Psychometric Properties of the Thoughts About Psychotherapy Survey in a Parent Sample.

Turner EA.

Community Ment Health J. 2018 Oct;54(7):930-934. doi: 10.1007/s10597-018-0248-6. Epub 2018 Feb 16.

PMID:
29453641
3.

The role of therapy fears, ethnic identity, and spirituality on access to mental health treatment among Latino college students.

Turner EA, Llamas JD.

Psychol Serv. 2017 Nov;14(4):524-530. doi: 10.1037/ser0000146.

PMID:
29120210
4.

HPLC-MS/MS method for quantification of paclitaxel from keratin containing samples.

Turner EA, Stenson AC, Yazdani SK.

J Pharm Biomed Anal. 2017 May 30;139:247-251. doi: 10.1016/j.jpba.2017.03.011. Epub 2017 Mar 10.

5.

Child Mental Health Services and Psychotherapy Attitudes Among Asian Indian Parents: An Exploratory Study.

Turner EA, Mohan S.

Community Ment Health J. 2016 Nov;52(8):989-997. Epub 2015 Dec 22.

PMID:
26694054
6.

Ethnicity as a moderator of how parents' attitudes and perceived stigma influence intentions to seek child mental health services.

Turner EA, Jensen-Doss A, Heffer RW.

Cultur Divers Ethnic Minor Psychol. 2015 Oct;21(4):613-8. doi: 10.1037/cdp0000047. Epub 2015 Apr 20.

PMID:
25894834
7.

Reply to Thomas: Diffusion of military technologies is a plausible explanation for the evolution of social complexity, 1500 BCE–AD 1500.

Turchin P, Currie T, Turner EA, Gavrilets S.

Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):E415. No abstract available.

8.

Assessing different mechanisms of toxicity in mountaintop removal/valley fill coal mining-affected watershed samples using Caenorhabditis elegans.

Turner EA, Kroeger GL, Arnold MC, Thornton BL, Di Giulio RT, Meyer JN.

PLoS One. 2013 Sep 16;8(9):e75329. doi: 10.1371/journal.pone.0075329. eCollection 2013.

9.

War, space, and the evolution of Old World complex societies.

Turchin P, Currie TE, Turner EA, Gavrilets S.

Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16384-9. doi: 10.1073/pnas.1308825110. Epub 2013 Sep 23.

10.

Making acute hospital exercises more realistic without impacting on healthcare delivery.

Riley PW, Dalby DJ, Turner EA.

J Bus Contin Emer Plan. 2012 Autumn-2013 Winter;6(2):143-50.

PMID:
23315249
11.

The parental attitudes toward psychological services inventory: adaptation and development of an attitude scale.

Turner EA.

Community Ment Health J. 2012 Aug;48(4):436-49. doi: 10.1007/s10597-011-9432-7. Epub 2011 Jun 21.

PMID:
21691821
12.

Comparative analysis of showering protocols for mass-casualty decontamination.

Amlot R, Larner J, Matar H, Jones DR, Carter H, Turner EA, Price SC, Chilcott RP.

Prehosp Disaster Med. 2010 Sep-Oct;25(5):435-9.

PMID:
21053192
13.

Intracellular uptake and associated toxicity of silver nanoparticles in Caenorhabditis elegans.

Meyer JN, Lord CA, Yang XY, Turner EA, Badireddy AR, Marinakos SM, Chilkoti A, Wiesner MR, Auffan M.

Aquat Toxicol. 2010 Oct 15;100(2):140-50. doi: 10.1016/j.aquatox.2010.07.016. Epub 2010 Jul 21.

PMID:
20708279
14.

Children's adjustment and child mental health service use: the role of parents' attitudes and personal service use in an upper middle class sample.

Turner EA, Liew J.

Community Ment Health J. 2010 Jun;46(3):231-40. doi: 10.1007/s10597-009-9221-8. Epub 2009 Jul 11. Erratum in: Community Ment Health J. 2010 Jun;46(3):241.

PMID:
19593640
15.

Promoting healthy lifestyles: Behavior modification and motivational interviewing in the treatment of childhood obesity.

Limbers CA, Turner EA, Varni JW.

J Clin Lipidol. 2008 Jun;2(3):169-78. doi: 10.1016/j.jacl.2008.03.003. Epub 2008 Mar 22.

PMID:
21291736
16.
17.

Characterization of ZnE (E = S, Se, or Te) materials synthesized using silylated chalcogen reagents in mesoporous MCM-41.

Turner EA, Rösner H, Fenske D, Huang Y, Corrigan JF.

J Phys Chem B. 2006 Aug 24;110(33):16261-9.

PMID:
16913752
18.

Investigations of the adsorption of n-pentane in several representative zeolites.

Wang H, Turner EA, Huang Y.

J Phys Chem B. 2006 Apr 27;110(16):8240-9.

PMID:
16623502
19.
20.

Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line.

Iyamu EW, Adunyah SE, Fasold H, Horiuchi K, Baliga S, Ohene-Frempong K, Turner EA, Asakura T.

Exp Hematol. 2003 Jul;31(7):592-600.

PMID:
12842704
21.

In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent.

Iyamu EW, Turner EA, Asakura T.

Br J Haematol. 2002 Jul;118(1):337-43.

PMID:
12100171
22.

Hb Inkster [alpha85(F6)Asp-->Val] found in a caucasian male with polycythemia.

Aguinaga MD, Kutlar F, Turner EA, Park D.

Hemoglobin. 2000 Nov;24(4):333-9. No abstract available.

PMID:
11186265
23.

Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia.

Buchowski MS, de la Fuente FA, Flakoll PJ, Chen KY, Turner EA.

Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E518-27.

24.

Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers.

Iyamu EW, Fasold H, Roa D, del Pilar Aguinaga M, Asakura T, Turner EA.

J Clin Lab Anal. 2001;15(1):1-7.

PMID:
11170226
25.

Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.

Shokrani M, Terrell F, Turner EA, Aguinaga MD.

Ann Clin Lab Sci. 2000 Apr;30(2):191-4.

PMID:
10807164
26.

Plasma leptin association with body composition and energy expenditure in sickle cell disease.

Buchowski MS, Simmons LA, Chen KY, Flakoll PJ, Mellen BG, Turner EA.

J Am Coll Nutr. 2000 Apr;19(2):228-36.

PMID:
10763904
27.
28.

Molecular diagnosis and characterization of Hb Zürich [beta63(E7)His-->Arg]] carriers in a Kentucky family.

Aguinaga MP, Wright CJ, Roa PD, Terrell F, Turner EA, Houston M.

Hemoglobin. 1998 Sep-Nov;22(5-6):509-15. No abstract available.

PMID:
9859934
29.

Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease.

Borel MJ, Buchowski MS, Turner EA, Goldstein RE, Flakoll PJ.

Am J Clin Nutr. 1998 Sep;68(3):607-14.

PMID:
9734737
30.

New isocratic high-performance liquid chromatographic procedure to assay the anti-sickling compound hydroxyurea in plasma with ultraviolet detection.

Iyamu EW, Roa PD, Kopsombut P, Aguinaga MD, Turner EA.

J Chromatogr B Biomed Sci Appl. 1998 May 8;709(1):119-26.

PMID:
9653933
31.

Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.

Iyamu EW, Adunyah SE, Elford HL, Fasold H, Turner EA.

Biochem Biophys Res Commun. 1998 Jun 29;247(3):759-64.

PMID:
9647767
32.

Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease.

Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ.

Am J Physiol. 1998 Feb;274(2):E357-64. doi: 10.1152/ajpendo.1998.274.2.E357.

PMID:
9486169
33.

A transgenic mouse model of hemoglobin S Antilles disease.

Popp RA, Popp DM, Shinpock SG, Yang MY, Mural JG, Aguinaga MP, Kopsombut P, Roa PD, Turner EA, Rubin EM.

Blood. 1997 Jun 1;89(11):4204-12.

34.

Tiazofurin-induced autosecretion of IL-6 and hemoglobin production in K562 human leukemia cells.

Talley CJ, Turner EA, Hatcher FM, Aguinaga PM, Chakrabarti P.

Am J Hematol. 1997 Apr;54(4):301-5.

35.

Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro.

Roa D, Kopsombut P, Aguinaga MP, Turner EA.

J Clin Lab Anal. 1997;11(4):208-13.

PMID:
9219062
36.

Reference ranges for hemoglobin variants by HPLC in African Americans.

Roa D, Turner EA, Aguinaga MD.

Ann Clin Lab Sci. 1995 May-Jun;25(3):228-35.

PMID:
7605104
37.

Severe anemia: a risk factor for glomerular injury in sickle cell disease.

Faulkner M, Turner EA, Deus J, Phillips K, Weaver C, Taiwo O, Omitowoju O.

J Natl Med Assoc. 1995 Mar;87(3):209-13.

38.

Hemoglobin variant detection from dried blood specimens by high performance liquid chromatography.

Roa PD, Turner EA, Aguinaga Mdel P.

Ann Clin Lab Sci. 1993 Nov-Dec;23(6):433-8.

PMID:
7507311
39.

ANA, Red Cross cite need for more RNs to be trained for disaster relief.

Turner EA.

Am Nurse. 1993 Sep;25(8):3. No abstract available.

PMID:
8285442
40.

Sickle cell disease with complicated influenza B virus infection.

Turner EA, Thompson HD, Reddy CM, South MA, Garrett-Ellis BR, Mirkovic RR.

J Natl Med Assoc. 1992 Jun;84(6):524-7.

41.

Profile of trauma due to violence in a statewide prison population.

Bragg WD, Hoover EL, Turner EA, Nelson-Knuckles B, Weaver WL.

South Med J. 1992 Apr;85(4):365-9.

PMID:
1566135
42.

Olfactory neuroblastoma (esthesioneuroblastoma) in a 2-year-old boy.

Woerner SJ, Lazerson J, Munn RJ, Turner EA.

Pediatr Hematol Oncol. 1986;3(2):167-74. Review.

PMID:
3153227
43.

Pentoxifylline (BL 191) by oral administration in the treatment of asthenozoospermia.

Aparicio NJ, Schwarzstein L, de Turner EA.

Andrologia. 1980 May-Jun;12(3):228-31.

PMID:
7004272
44.

Effect of the phosphodiesterase inhibitor Pentoxyfylline on human sperm motility.

Aparicio NJ, de Turner EA, Schwarzstein L, Turner D.

Andrologia. 1980 Jan-Feb;12(1):49-54.

PMID:
7377553
45.

Non-chromatographic radioimmunoassay procedure for urinary aldosterone.

Walsh PR, Wang MC, Turner EA.

Clin Chem. 1979 Jul;25(7):1226-9.

46.

D-leucine-6-luteinizing hormone-releasing hormone ethylamide in the treatment of normogonadotropic oligoasthenospermia.

Schwarzstein L, Aparicio NJ, Turner D, De Turner EA, Premoli F, Schally AV.

Fertil Steril. 1978 Mar;29(3):332-5.

PMID:
346384
47.

Pituitary and testicular response to LH-RH and to a long-acting analogue (D-leu-6-LH-RH-ethylamide).

Schwarzstein L, Aparicio NJ, Turner D, de Turner EA, Schally AV, Coy DH.

Andrologia. 1978 Jan-Feb;10(1):59-65.

PMID:
343641
48.
49.

Treatment of idiopathic normogonadotropic oligoasthenospermia with synthetic luteinizing hormone-releasing hormone.

Aparicio NJ, Schwarzstein L, Turner EA, Turner D, Mancini R, Schally AV.

Fertil Steril. 1976 May;27(5):549-55.

PMID:
776708
50.

Response of luteinizing hormone and follicle-stimulating hormone to different doses of D-leucine-6-LH-RH ethylamide in oligospermic patients.

Turner D, Turner EA, Aparicio NJ, Schwarzstein L, Coy DH, Schally AV.

Fertil Steril. 1976 May;27(5):545-8.

PMID:
776707

Supplemental Content

Loading ...
Support Center